Chuanbo Xu

Chuanbo Xu has a diverse range of work experience in the medical and biotech industries. Chuanbo is currently working at Freenome as the Senior Director of Clinical Development. Prior to this, they served as the Chief Medical Officer at Vienomics and as the Vice President of Business Development and Medical Advisor at Gulf Investment. Chuanbo Xu also has experience as the CEO of Labway USA, where they established and led the US subsidiary of Labway Shanghai. Chuanbo has also held positions at GRAIL, Inc. as a Clinical Program Manager, Illumina as a Clinical Project Manager, Wako Diagnostics as the Director of Clinical & Regulatory Affairs, and CDx Pro Associates, LLC as the Owner & Principal. Chuanbo Xu has extensive experience in clinical diagnostics, regulatory affairs, and oncology research. Chuanbo has led and managed teams, developed growth strategies, and achieved regulatory approvals for multiple diagnostic kits.

Chuanbo Xu has a diverse education history. Chuanbo first attended Jilin Agricultural University from 1979 to 1983, where they earned a degree in Veterinary Medicine (DVM). Chuanbo then pursued further studies at the Chinese Academy of Agricultural Sciences from 1983 to 1987, obtaining a Ph.D. in Immunology. In 1992 and 1993, Xu attended Université Paris Cité, where they earned a DESS degree in Bioinformatics. Lastly, in 2006 and 2007, Xu attended the Project Management Institute to earn a certification as a Project Management Professional (PMP).